A new national survey shows strong, bipartisan support for expanding America’s bioindustrial manufacturing capabilities. BioMADE released the results Monday, working in partnership with YouGov.
The findings span regions, demographics, and political affiliations. Fifty-six percent of Americans want more American-made, bio-based products on store shelves and in the supply chain. Only five percent disagree.
Six in ten respondents believe the federal government should invest in biomanufacturing research and production. They see this as a way to reduce reliance on foreign supply chains and strengthen national competitiveness. Again, just five percent disagreed.
Fifty-nine percent said the U.S. must fight to remain a global leader in biomanufacturing, rather than fall behind China, India, and the European Union.
That competition is already underway. China invests at least $4.3 billion annually in biomanufacturing and plans to build 20 pilot-scale plants by 2027. India is constructing more than 20 new facilities and aims to double the economic impact of its biomanufacturing sector by 2030. The European Union already has at least twice the fermentation capacity of the United States.
Douglas Friedman, chief executive officer at BioMADE, said the survey results reflect what the organization hears nationwide. He pointed to bioindustrial manufacturing’s potential to create jobs, support domestic supply chains, and cut reliance on foreign imports.
Friedman also noted the scale of investment from other countries. He said Americans are not just open to federal investment in biomanufacturing. According to Friedman, they are “expecting it.”
BioMADE said it remains focused on strengthening the sector’s global competitiveness. The organization also emphasized advancing innovation and supporting continued U.S. momentum in biomanufacturing.
